Streetbeat News

Price Targets

AORT

Needham analyst Mike Matson has reiterated a Buy rating on Artivion (NYSE:AORT) and maintained a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 9:36 am

DFIN

Needham analyst Kyle Peterson has reiterated a Buy rating on Donnelley Financial Solutions (NYSE:DFIN) and maintained a price target of $79.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 9:34 am

KMX

Needham analyst Chris Pierce maintains a Buy rating on CarMax (NYSE:KMX) and raises the price target from $87 to $90.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 9:31 am

LI

Li Auto has seen significant bullish interest from large investors in its options market, with 55% of trades being bullish. The stock is currently trading at $25.31, up 6.48%, but RSI suggests it may be overbought. Investors are eyeing a price range of $20 to $40.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:46 pm

BMEA

Rodman & Renshaw has upgraded Biomea Fusion (NASDAQ:BMEA) from Neutral to Buy, setting a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:07 pm

MU

Micron Technology, Inc (NASDAQ:MU) reported strong quarterly results, surpassing revenue and EPS estimates. Analysts have raised price targets, citing strong demand for AI-driven HBM and data center growth. The stock is up 15.70% following the positive outlook.

Portfolio Pulse from Anusuya Lahiri

September 26, 2024 | 7:37 pm

BBWI

Telsey Advisory Group has reiterated its 'Outperform' rating for Bath & Body Works (NYSE:BBWI) with a maintained price target of $42.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:56 pm

RL

Telsey Advisory Group has reiterated its 'Outperform' rating for Ralph Lauren, maintaining a price target of $207. This suggests confidence in Ralph Lauren's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:48 pm

ENLV

EF Hutton analyst Jason Kolbert has reiterated a Buy rating for Enlivex Therapeutics (NASDAQ:ENLV) and maintained a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:38 pm

DAVE

Barrington Research analyst Gary Prestopino has reiterated an 'Outperform' rating for Dave (NASDAQ:DAVE) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 6:33 pm